Ligand-Based Pharmacophore Modeling and Virtual Screening of RAD9 Inhibitors

Figure 5

RAD9 and ligands interacting conformations (a), RAD9 and NSC15520 interacting complex, and (b) RAD9 and camptothecin interacting complex.

(a)

(b)